The Role of Antidepressants or Antipsychotics in Preventing Psychosis

Status Withdrawn

Clinical Trial Summary

This is a randomized, controlled pilot study comparing the antidepressant fluoxetine with the second generation antipsychotic aripiprazole in approximately 10 subjects aged 12-25 at risk for developing psychosis.

Our primary hypotheses are that compared to aripiprazole, fluoxetine will be better tolerated and will lead to greater improvement in symptoms at the end of 6 months of treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01724372
Study type	Interventional
Source	St. Luke's-Roosevelt Hospital Center
Contact
Status	Withdrawn
Phase	N/A
Start date	October 2012
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02306551` - Well Being And Resilience: Mechanisms of Transmission of Health and Risk
Active, not recruiting	`NCT00627029` - Evaluation of Programs of Coordinated Care and Disease Management	N/A
Terminated	`NCT00049738` - Screening for Childhood-Onset Psychotic Disorders	N/A
Completed	`NCT00716755` - Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.	N/A
Completed	`NCT00498550` - Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual	Phase 4
Terminated	`NCT04140773` - The Effect of D-serine as add-on Therapy in Recent-onset Psychosis	N/A
Completed	`NCT01473550` - Mental Health Engagement Network (MHEN)	N/A
Completed	`NCT01207219` - Yoga and Aerobic Exercise in Psychosis	N/A
Completed	`NCT00397033` - Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.	Phase 3
Recruiting	`NCT04945278` - Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability	N/A
Completed	`NCT03955250` - Mobile After-Care Support App: Pilot RCT	N/A
Completed	`NCT00287352` - Study of Amantadine for Weight Stabilization During Olanzapine Treatment	Phase 1
Completed	`NCT00005658` - Glycine to Treat Psychotic Disorders in Children	Phase 2
Terminated	`NCT00169026` - Alcoholism and Schizophrenia: Effects of Clozapine	Phase 4
Completed	`NCT00001482` - New Drugs in the Treatment of Mood Disorders	Phase 2
Terminated	`NCT03671005` - Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders	N/A
Completed	`NCT00095524` - Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder	Phase 3
Completed	`NCT00156715` - Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder	Phase 4
Completed	`NCT03667729` - The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia	N/A
Completed	`NCT00001656` - Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders	Phase 4